| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022102693 |
| P356 | DOI | 10.1186/1471-2334-6-100 |
| P932 | PMC publication ID | 1569838 |
| P698 | PubMed publication ID | 16784542 |
| P5875 | ResearchGate publication ID | 6998549 |
| P2093 | author name string | Vincent T K Chow | |
| P Gopalakrishnakone | |||
| Ho Bow | |||
| A Pachiappan | |||
| R Perumal Samy | |||
| Joseph T Weng | |||
| Maung M Thwin | |||
| Yap E Hian | |||
| P2860 | cites work | Melioidosis | Q56286799 |
| Antibacterial properties of KwaZulu natal snake venoms | Q62489721 | ||
| Burkholderia pseudomallei: the unbeatable foe? | Q64049916 | ||
| Antibacterial action of melittin, a polypeptide from bee venom | Q69840686 | ||
| Pseudomonas pseudomallei: Susceptibility to Chemotherapeutic Agents | Q70811548 | ||
| A major lethal factor of the venom of Burmese Russell's viper (Daboia russelli siamensis): isolation, N-terminal sequencing and biological activities of daboiatoxin | Q72305468 | ||
| Peptide antibiotics | Q73073957 | ||
| Polymorphism in the promoter region of tumor necrosis factor-alpha gene is associated with severe meliodosis | Q73194139 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Halving of mortality of severe melioidosis by ceftazidime | Q28257666 | ||
| Melioidosis: an emerging infection in Taiwan? | Q28366065 | ||
| Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. | Q30723475 | ||
| De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis. | Q30752566 | ||
| Structural and functional characterization of basic PLA2 isolated from Crotalus durissus terrificus venom. | Q31058316 | ||
| Analysis of cDNAs encoding the two subunits of crotoxin, a phospholipase A2 neurotoxin from rattlesnake venom: the acidic non enzymatic subunit derives from a phospholipase A2-like precursor. | Q33530997 | ||
| Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature | Q33922796 | ||
| The role of antimicrobial peptides in animal defenses | Q33988529 | ||
| Melioidosis research in China | Q34083699 | ||
| Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases | Q34092336 | ||
| Relapse in melioidosis: incidence and risk factors | Q34344002 | ||
| A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis | Q34371469 | ||
| Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand | Q34522534 | ||
| Antibacterial effects of different snake venoms: Purification and characterization of antibacterial proteins from Pseudechis australis (Australian king brown or mulga snake) venom | Q34584235 | ||
| Burkholderia Is Highly Resistant to Human Beta-Defensin 3 | Q34941575 | ||
| Septicaemic melioidosis: a review of 50 cases from Malaysia | Q35184325 | ||
| Intracellular survival of Burkholderia pseudomallei | Q35472694 | ||
| Glial inflammation and neurodegeneration induced by candoxin, a novel neurotoxin from Bungarus candidus venom: global gene expression analysis using microarray | Q38318464 | ||
| Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis | Q39465365 | ||
| Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis | Q39478540 | ||
| Burkholderia pseudomallei and melioidosis: be aware in temperate area | Q40385900 | ||
| From noxiustoxin to Shiva-3, a peptide toxic to the sporogonic development of Plasmodium berghei | Q40837909 | ||
| Antimicrobial peptides of leukocytes. | Q41363977 | ||
| A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. | Q41857195 | ||
| Peptide antibiotics in mast cells of fish | Q44876761 | ||
| Bactericidal and neurotoxic activities of two myotoxic phospholipases A2 from Bothrops neuwiedi pauloensis snake venom | Q45012401 | ||
| Analysis of human synovial fluid phospholipase A2 on short chain phosphatidylcholine-mixed micelles: development of a spectrophotometric assay suitable for a microtiterplate reader | Q45169254 | ||
| Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom--synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region | Q47881529 | ||
| Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae). | Q52576342 | ||
| Antibacterial activity of crotalid venoms against oral snake flora and other clinical bacteria. | Q54292593 | ||
| The action of various venoms on Escherichia coli. | Q54773532 | ||
| P921 | main subject | Burkholderia pseudomallei | Q140475 |
| venom | Q3386847 | ||
| P304 | page(s) | 100 | |
| P577 | publication date | 2006-06-20 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei | |
| P478 | volume | 6 |
| Q33652237 | Antibacterial Activity of Isolated Immunodominant Proteins of Naja Naja (Oxiana) Venom |
| Q38256053 | Antibacterial activity of an acidic phospholipase A2 (NN-XIb-PLA2) from the venom of Naja naja (Indian cobra) |
| Q41186048 | Antibacterial potential of a basic phospholipase A2 (VRV-PL-VIIIa) from Daboia russelii pulchella (Russell's viper) venom |
| Q38560919 | Antibacterial properties of L-amino acid oxidase: mechanisms of action and perspectives for therapeutic applications |
| Q55630844 | Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients. |
| Q42012466 | Assessment of the Antimicrobial Activity of Few Saudi Arabian Snake Venoms |
| Q37298234 | Bee Venom (Apis Mellifera) an Effective Potential Alternative to Gentamicin for Specific Bacteria Strains: Bee Venom an Effective Potential for Bacteria |
| Q34394263 | Cobra cytotoxins: structural organization and antibacterial activity |
| Q37456678 | Effect of Ottoman Viper (Montivipera xanthina (Gray, 1849)) Venom on Various Cancer Cells and on Microorganisms |
| Q91752225 | Harnessing snake venom phospholipases A2 to novel approaches for overcoming antibiotic resistance |
| Q60044479 | Immunotherapeutic potential of Crotoxin: anti-inflammatory and immunosuppressive properties |
| Q28554831 | In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model |
| Q40322851 | In vitro antibacterial effect of wasp (Vespa orientalis) venom |
| Q39077760 | Molecular characterization of Lys49 and Asp49 phospholipases A₂from snake venom and their antiviral activities against Dengue virus |
| Q111346636 | Molecular cloning and antibacterial activity of bombolitin isolated from the venom of a bumblebee, Bombus terrestris |
| Q92914862 | Predicting antibacterial activity from snake venom proteomes |
| Q41141374 | The Antimicrobial Activity of an Acidic Phospholipase A₂ (NN-XIa-PLA₂) from the Venom of Naja naja naja (Indian Cobra). |
| Q34538191 | Treatment and prophylaxis of melioidosis |
| Q35899816 | Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent. |
| Q35097174 | Wound healing activity and mechanisms of action of an antibacterial protein from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus) |
Search more.